Clinical Trials Logo

Filter by:
NCT ID: NCT06410222 Enrolling by invitation - Clinical trials for Post Herpetic Neuralgia

Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.

Start date: March 1, 2024
Phase:
Study type: Observational

Shingles is a neuropathic disease caused by varicella-herpes virus(VZV) invading nerves and accompanying pain.Currently, the treatment of postherpetic neuralgia (PHN) includes medication and minimally invasive interventional therapy.In patients with herpes zoster neuralgia treated with spinal cord stimulation (SCS), some patients have satisfactory pain relief after surgery, but some patients have pain symptoms again some time after surgery. The reason for this difference in treatment effect is not clear.

NCT ID: NCT06408571 Enrolling by invitation - Clinical trials for Metabolomics; Retinopathy; Etiology

Study on the Pathogenesis of Retinal Vascular Diseases Based on Body Fluid Metabolomics

Start date: September 7, 2023
Phase:
Study type: Observational

Through the analysis of metabolites in body fluids (intraocular fluid, plasma) of patients with retinal vascular diseases (retinal vein occlusion, diabetic retinopathy), the possible pathogenesis of retinal vein occlusion was explored.

NCT ID: NCT06401161 Enrolling by invitation - Obesity Clinical Trials

Study on the Effect of 3T Pu'er Tea in Regulating Glucose and Lipid Metabolism

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

To study the effect of Pu'er tea in overweight / obese patients with blood glucose or abnormal lipid metabolism. Compared with the effect of two Pu'er tea with different tea fuscin content in improving glucose and lipid metabolism, to investigate the mechanisms of bile acid metabolism and intestinal flora regulation. In a prospective randomized controlled clinical study, 90 patients were divided into study group (3T Pu'er tea group, 45 patients) and control group ( traditional Pu'er tea group,45 patients). Before and after the treatment(0day, 12 weeks, 52 weeks) patients' markers of glucose and lipid metabolism were examined and compared.

NCT ID: NCT06395961 Enrolling by invitation - Diabetic Foot Ulcer Clinical Trials

Effect of New High Ankle Block on Wound Healing After the Operation of Debridement of Diabetes Foot

Start date: August 2, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare high ankle block and general anesthesia on wound recovery and ankle blood flow perfusion after diabetes foot surgery in diabetics. The main questions it aims to answer are: - weather the high ankle block can fast wound recovery after the surgery - weather the high ankle block can improve ankle blood flow perfusion after the surgery Participants will receive either high ankle block or general anesthesia during surgery. After the operation, foot ulcer area and pulse perfusion index will be measured on the postoperative day of 1 and 14; lower limb hemodynamic parameters will be measured by ultrasound on the postoperative days of 1, 7, and 14. Researchers will compare high ankle block and general anesthesia to see if they have the different on the wound recovery and blood flow perfusion of the patients' foot.

NCT ID: NCT06387641 Enrolling by invitation - Clinical trials for Disabilities, Psychological

Effects of Life Review Intervention on Meaning in Life Among Older Adults With Disabilities

Start date: March 25, 2024
Phase: N/A
Study type: Interventional

The goal of this interventional study is to learn if life review works to improve the sense of meaning in life in older adults with disabilities who live at home. The main questions it aims to answer are: Does life review enhance the sense of meaning in life of participants? Does life reviews enhance the life satisfaction of participants. Does life reviews enhance the quality of life of participants? Researchers will compare the life review program to routine community health services to see if the life review intervention program is effective in enhancing the sense of meaning in life of older adults with disabilities who live at home. Participants will: Take face-to-face life review interview or routine community health service every week for 6 weeks. Take the the questionnaire survey before and after the six-week life review intervention.

NCT ID: NCT06380868 Enrolling by invitation - Diabetes Clinical Trials

IVI-guided Versus Angiography-guided PCI in Patients With Diabetes Mellitus

IVI-DIABETES
Start date: June 10, 2024
Phase: N/A
Study type: Interventional

Intravascular ultrasound (IVUS) serves as a beneficial instrument during percutaneous coronary intervention (PCI) procedures, affording insight into lesion characteristics and stent implantation. The ULTIMATE trial recently evidenced that IVUS-guided Drug-Eluting Stent (DES) implantation notably ameliorated clinical outcomes in all-comers, especially in patients who underwent an optimal procedure defined by IVUS, as opposed to angiography guidance, resonating with findings from the IVUS-XPL study, OCTOBER trial, and RENOVATE COMPLEX PCI trial, further confirmed by more recent IVUS-ACS trial. Optical coherence tomography (OCT) has a resolution 10 times higher than that of IVUS and can provide valuable information at each step of PCI. Regrettably, a dearth of prospective, randomized, multicenter trials exists that scrutinize the benefits of IVI-guided as opposed to angiography-guided PCI in patients suffering from diabetes mellitus. However, several trials have presented subgroup analyses reporting the reduction of clinical events by IVUS but not OCT guidance in patients with diabetes mellitus, which served as the foundation for the design of this trial.

NCT ID: NCT06375148 Enrolling by invitation - Enteral Nutrition Clinical Trials

A Questionnaire Survey on Cognition of Enteral Nutrition Implementation in Patients Requiring Mechanical Ventilation in Prone Position

Start date: March 20, 2024
Phase:
Study type: Observational

Prone ventilation is an important treatment for respiratory failure with intractable hypoxia, and the Corona Virus Disease 2019(COVID-19 ) outbreak has further elevated the status of prone ventilation. Early enteral nutrition (EN) is also recognised as an important measure to improve the prognosis of critically ill patients. However, the administration of enteral nutrition during prone position is still quite controversial. In this paper, we analysed the tolerance and safety of enteral nutrition in the prone position by reviewing studies before and after the COVID-19 outbreak. Key strategies to improve the tolerability of enteral nutrition in the prone position are also summarised and discussed.

NCT ID: NCT06373575 Enrolling by invitation - Clinical trials for End-stage Renal Disease

IVC and Lung Ultrasound B-lines Guided Decongestion in Critically Ill ESKD Patients With Heart Failure

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The objectives of this trial are to determine whether, in critically ill ESKD patients randomization to fluid removal guided by lung and inferior vena cava ultrasound, compared to standard care, leads to Improved pulmonary congestion (primary outcome); and safety (secondary outcome) in the short-term.

NCT ID: NCT06371326 Enrolling by invitation - Clinical trials for Overweight or Obesity

A Study of ZT002 Injection in Participants With Overweight or Obesity

Start date: November 21, 2023
Phase: Phase 1
Study type: Interventional

This study will comprise a randomized, double-blind, placebo-controlled, multiple-ascending-dose, safety, tolerability, and pharmacokinetics study of ZT002 in participants with Overweight or Obesity.

NCT ID: NCT06367127 Enrolling by invitation - Clinical trials for Hepatic Encephalopathy

Utility of the Clamping Bean Test (CBT) for Covert Hepatic Encephalopathy Screening

Start date: October 9, 2023
Phase:
Study type: Observational [Patient Registry]

Hepatic encephalopathy is a brain dysfunction caused by liver insufficiency and/or porto-systemic shunt. It manifests as a wide spectrum of neurological or psychiatric abnormalities ranging from subclinical alterations to coma. According to the symptoms, it is classified as covert HE (CHE) and overt HE (OHE). CHE can progress to OHE and is associated with reduced driving ability, increased risk of accidents and hospitalization and weakened health-related quality of life, resulting in poor prognosis and socio-economic status. However, due to the absence of readily identifiable clinical symptoms and signs, CHE is often neglected in clinical practice. Presently, the diagnosis of CHE depends on psychometric and neurophysiological tests, including the psychometric hepatic encephalopathy score (PHES), critical flicker frequency (CFF) test, continuous reaction time (CRT) test, inhibitory control test, the SCAN test, and electroencephalography. Among them, PHES is most widely used and recommended by several guidelines. However, it is difficult to screen CHE among all cirrhotic patients in the clinic using PHES because of the time required and a dependence on trained experts. Moving beans from one container to another with tweezers involves dexterity, agility and coordination.The hypothesis was that the utility of the Clamping Bean Test (CBT) will enable early screening patients with CHE.